Disease Site Groups

The Cardinal Bernardin Cancer Center has 12 Disease Site Groups (DSGs) — each with clinical research and non-clinical research leaders. The DSG Research teams oversee science in their respective groups, provide oversight of the clinical trial portfolio, monitor trial progress, and select trials that meet the needs of their respective disease sites.

The DSG research leaders provide a first-stage review of all new investigator-sponsored trials before submission to the Protocol Review and Monitoring Committee (PRMC).

CBCC Disease Group Research Leadership

Breast Oncology  

Kathy Albain, MD
Clodia Osipo, PhD

Gastrointestinal Oncology 

Andrea Amico, MD
Ali Vaziri-Gohar, PhD

Gynecologic Oncology 

Matthew Harkenrider, MD
Maureen Drakes, PhD

Head and Neck Oncology 

Eric Thorpe, MD

Hematology, Cellular Therapy and BMT 

Stephanie Tsai, MD 
Jiwang Zhang, MD, PhD

Neuro-Oncology 

Vikram Prabhu, MD
Derek Wainwright, PhD

Thoracic Oncology 

Kathy Albain, MD 
Nan Sethakorn, MD, PhD

Urologic Oncology 

Abhishek Solanki, MD
Steve Kregel, PhD

Pediatric Oncology 

Eugene Suh, MD

Melanoma and Other Skin Cancers 

Joseph Clark, MD
Mitchell Denning, PhD

Sarcoma, Miscellaneous 

Thomas Hodo, MD

Survivorship, Integrative Oncology 

Sarah Thilges, PhD
Patricia Sheean, PhD